Monsanto Should Pay $857 Million in PCB Case, Jury Finds
Posted inBayer AG Cancer Compensation for Damages (Law) Decisions and Verdicts Drugs (Pharmaceuticals) Environment Hazardous and Toxic Substances King County (Wash) Mergers, Acquisitions and Divestitures Monsanto Company Seattle (Wash) Washington (State)

Monsanto Should Pay $857 Million in PCB Case, Jury Finds

Students and parent volunteers from a school in Washington State said in a lawsuit that they had become sick after being exposed to chemicals known as PCBs that had dripped from light fixtures.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
Posted inBlood Bone Marrow Crispr (DNA) Developing Countries Drugs (Pharmaceuticals) Food and Drug Administration Genetic Engineering Genetics and Heredity Income Inequality Sickle Cell Anemia Stem Cells Therapy and Rehabilitation Transplants Vertex Pharmaceuticals Inc

New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most

There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.